Claim · claimSorter/cs-054

The extraction of indigenous pharmacological knowledge without benefit-sharing constitutes biopiracy under international law

Education, not medical advice. Drafts and study material from an independent research library. Citations on this page were checked on Oct 13, 2026; claims in the body text and organizational sources are still under review. What was checked.

The extraction of indigenous pharmacological knowledge without benefit-sharing constitutes biopiracy under international law

Confirmed recorded as “Confirmed By Treaty” The Cosmic Serpent

The Nagoya Protocol (2010, in force 2014) defines misappropriation of genetic resources and associated traditional knowledge without prior informed consent and benefit-sharing as a violation of international law. 143 states are parties. The ayahuasca patent case (US Patent 5751 to Loren Miller, challenged 1999) established the legal category in US law. Whether the psychedelic pharmaceutical industry's development of psilocybin, ibogaine, and mescaline derivatives from ethnobotanically-derived knowledge constitutes Nagoya-covered biopiracy is legally contested; the moral argument is established.